Importer of Controlled Substances Application: Almac Clinical Services Incorp (ACSI), 80387 [2015-32367]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 247 / Thursday, December 24, 2015 / Notices
Controlled substance
Schedule
Lysergic acid diethylamide (7315)
Heroin (9200) ...............................
Meperidine (9230) ........................
I
I
II
The company plans to import these
controlled substances for the
manufacture of reference standards.
Dated: December 15, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015–32370 Filed 12–23–15; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Dated: December 15, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Almac Clinical Services
Incorp (ACSI)
ACTION:
mstockstill on DSK4VPTVN1PROD with NOTICES
[FR Doc. 2015–32367 Filed 12–23–15; 8:45 am]
BILLING CODE 4410–09–P
Notice of application.
DEPARTMENT OF LABOR
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
January 25, 2016. Such persons may
also file a written request for a hearing
on the application pursuant to 21 CFR
1301.43 on or before January 25, 2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
DATES:
VerDate Sep<11>2014
17:57 Dec 23, 2015
Jkt 238001
In accordance with 21 CFR
1301.34(a), this is notice that on
September 1, 2015, Almac Clinical
Services Incorp (ACSI), 25 Fretz Road,
Souderton, Pennsylvania 18964 applied
to be registered as an importer of
Morphine (9300), a basic class of
controlled substance listed in schedule
II.
The company plans to import the
listed controlled substance in dosage
form, for clinical trial only. Approval of
permit applications will occur only
when the registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of FDA
approved or non-approved finished
dosage forms for commercial sale.
Employment and Training
Administration
Comment Request for Information
Collection for Form ETA–9142A, H–2A
Application for Temporary
Employment Certification, and
Appendix A (OMB Control Number
1205–0466), Revision
Employment and Training
Administration (ETA), Labor.
ACTION: Notice.
AGENCY:
The Department of Labor
(Department or DOL), as part of its
continuing effort to reduce paperwork
and respondent burden, conducts a
preclearance consultation program to
provide the public and Federal agencies
with an opportunity to comment on
proposed and/or continuing collections
of information in accordance with the
Paperwork Reduction Act of 1995 (44
U.S.C. 3506(c)(2)(A)). This program
helps ensure that requested data can be
provided in the desired format,
reporting burden (time and financial
resources) is minimized, collection
instruments are clearly understood, and
the impact of collection requirements on
respondents can be properly assessed.
Currently, the Employment and
Training Administration (ETA) is
soliciting comments concerning the
collection of data on the Form ETA–
9142A, H–2A Application for
Temporary Employment Certification,
and Appendix A (OMB Control Number
1205–0466), which expire on March 31,
2016. A copy of the proposed
SUMMARY:
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
80387
information collection request can be
obtained free of charge by contacting the
office listed below in the addressee
section of this notice.
The forms are used by employers in
the H–2A temporary agricultural
employment-based program to collect
information that demonstrates
compliance with program requirements.
DATES: Written comments must be
submitted to the office listed in the
addresses section below on or before
February 22, 2016.
ADDRESSES: Submit written comments
to Brian Pasternak, National Director of
Temporary Programs, Office of Foreign
Labor Certification, Employment &
Training Administration, U.S.
Department of Labor, 200 Constitution
Avenue, Box 12–200 NW., Washington,
DC 20210; Telephone: (202) 513–7350
(this is not a toll-free number).
Individuals with hearing or speech
impairments may access the telephone
number above via TTY by calling the
toll-free Federal Information Relay
Service at 1–877–889–5627 (TTY/TDD).
Fax: 202–513–7495. Email:
ETA.OFLC.Forms@dol.gov subject line:
ETA–9141A. A copy of the proposed
information collection request (ICR) can
be obtained free of charge by contacting
the office listed above.
SUPPLEMENTARY INFORMATION:
I. Background
The information collection (IC) is
required by sections 101(a)(15)(H)(ii)(a);
214(c); and 218 of the Immigration and
Nationality Act (INA) (8 U.S.C.
1011(a)(15)(H)(ii)(a), 1184(c), and 1188)
and 8 CFR 214.2(h). Before an employer
may petition for any temporary foreign
workers, it must submit a request for
certification to the Secretary of Labor
containing the elements prescribed by
the INA and the Department’s
implementing regulations, which differ
depending on the visa program under
which the foreign workers are sought.
The H–2A program enables employers
to bring nonimmigrant foreign workers
to the U.S. to perform agricultural work
of a temporary or seasonal nature as
defined in 8 U.S.C. 1101(a)(15)(H)(ii)(a).
For purposes of the H–2A program, the
INA and governing federal regulations
require the Secretary of Labor to certify,
among other things, that any foreign
worker seeking to enter the United
States (U.S.) temporarily for the purpose
of performing certain unskilled labor
will not, by doing so, adversely affect
wages and working conditions of U.S.
workers similarly employed. The
Secretary must also certify that there are
not sufficient U.S. workers available to
E:\FR\FM\24DEN1.SGM
24DEN1
]]>Agencies
[Federal Register Volume 80, Number 247 (Thursday, December 24, 2015)]
[Notices]
[Page 80387]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32367]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Almac Clinical
Services Incorp (ACSI)
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before January 25, 2016. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before January 25, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on
September 1, 2015, Almac Clinical Services Incorp (ACSI), 25 Fretz
Road, Souderton, Pennsylvania 18964 applied to be registered as an
importer of Morphine (9300), a basic class of controlled substance
listed in schedule II.
The company plans to import the listed controlled substance in
dosage form, for clinical trial only. Approval of permit applications
will occur only when the registrant's business activity is consistent
with what is authorized under 21 U.S.C. 952(a)(2). Authorization will
not extend to the import of FDA approved or non-approved finished
dosage forms for commercial sale.
Dated: December 15, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-32367 Filed 12-23-15; 8:45 am]
BILLING CODE 4410-09-P
